www.fdanews.com/articles/88161-pharma-blog-watch
Pharma Blog Watch
July 6, 2006
New
ARV Combination Treatment (DrugWonks.com)
In his entry, blogger Peter
Pitts writes about the new 3-in-1 antiretroviral (ARV) HIV/AIDS treatment developed
by Aurobindo Pharma, which was recently approved by the FDA.
Canadian
DTC Advertising in the U.S. (Eye on FDA)
Why would direct-to-consumer
(DTC) advertising solicit U.S. consumers to buy Canadian drugs? Blogger Mark Senak
writes about cross-border ad campaigns in his entry.